| 1 |
35080036 | Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study. | 2022 May |
2 |
| 2 |
33272733 | Optimization of azathioprine dose in combined treatment with anti-TNF-alpha in inflammatory bowel disease. | 2021 May |
1 |
| 3 |
33813036 | Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination Therapy. | 2021 |
1 |
| 4 |
32232050 | Long-Term Prognosis of Japanese Patients with Crohn's Disease Treated by Switching Anti-Tumor Necrosis Factor-α Antibodies. | 2020 Feb |
1 |
| 5 |
32363635 | Predicted efficacy of a pharmacogenetic passport for inflammatory bowel disease. | 2020 Jun |
1 |
| 6 |
29079905 | Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn's Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability. | 2018 Feb |
4 |
| 7 |
29655835 | Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases. | 2018 Aug |
2 |
| 8 |
28045204 | Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study. | 2017 Jun |
1 |
| 9 |
26511478 | Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients. | 2016 Jan |
1 |
| 10 |
26978723 | Thiopurine Metabolism in the Era of Combotherapy. | 2016 Jun |
1 |
| 11 |
27063728 | Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection. | 2016 Jul |
1 |
| 12 |
28028358 | Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective. | 2016 Dec 14 |
1 |
| 13 |
25600263 | Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease. | 2015 Apr |
1 |
| 14 |
26130995 | Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future. | 2015 Jul |
1 |
| 15 |
26226548 | Effect of Inflammatory Bowel Disease-Related Characteristics and Treatment Interventions on Cardiovascular Disease Incidence. | 2015 Sep |
1 |
| 16 |
23978351 | Phenotypic features of Crohn's disease associated with failure of medical treatment. | 2014 Mar |
2 |
| 17 |
25267954 | Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System. | 2014 Sep |
1 |
| 18 |
23662928 | Addition of thiopurines can recapture response in patients with Crohn's disease who have lost response to anti-tumor necrosis factor monotherapy. | 2013 Oct |
3 |
| 19 |
23987103 | Cancer risk in immune-mediated inflammatory diseases (IMID). | 2013 Aug 29 |
1 |
| 20 |
20888436 | A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. | 2011 Jan |
1 |
| 21 |
22031357 | Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease. | 2011 Dec |
2 |
| 22 |
20932143 | Thiopurine therapy in inflammatory bowel disease. | 2010 Oct |
1 |
| 23 |
19716247 | [Inflammatory bowel disease: from sulfasalazine to biologics]. | 2009 Aug-Sep |
1 |